Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:19   Issue: 3
Pp: 161-161
M.P. Carty
DOI: 10.2174/156800961903190214151927

Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors

Volume:19   Issue: 3
Pp: 179-188
Arkene Levy*, Khalid Alhazzani, Priya Dondapati, Ali Alaseem, Khadijah Cheema, Keerthi Thallapureddy, Paramjot Kaur, Saad Alobid and Appu Rathinavelu
DOI: 10.2174/1568009618666180706165222

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Volume:19   Issue: 3
Pp: 199-209
Bing-Di Yan, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen and Lei Yang*
DOI: 10.2174/1568009618666180430124738

The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine

Volume:19   Issue: 3
Pp: 222-230
Gracia Montag, Helga Stopper, Quoc Anh Ngo and Henning Hintzsche*
DOI: 10.2174/1568009618666180430142233

Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Volume:19   Issue: 3
Pp: 231-242
Md Zahidul I. Pranjol, Nicholas J. Gutowski, Michael Hannemann and Jacqueline L. Whatmore*
DOI: 10.2174/1568009618666180831123951